Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100001M79
HKD
22.52
0.24 (1.08%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Dec'17
Dec'16
Net Sales
50,947.30
46,839.53
33,894.26
32,191.07
29,272.45
21,172.53
16,948.59
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
50,947.30
46,839.53
33,894.26
32,191.07
29,272.45
21,172.53
16,948.59
Raw Material Cost
26,943.53
24,381.16
15,092.53
13,089.28
12,277.23
8,773.78
7,849.86
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
10,884.80
9,119.33
6,245.16
5,664.57
4,739.72
3,446.53
2,712.02
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1,120.79
991.33
989.92
1,218.61
1,101.14
665.95
570.39
Selling and Distribution Expenses
15,294.51
15,052.07
13,040.34
14,285.78
12,798.70
8,687.44
6,228.22
Other Expenses
-700.28
-548.59
-409.38
-456.84
-408.83
-292.88
-244.73
Total Expenditure (Excl Depreciation)
47,240.84
44,057.99
31,274.14
29,689.83
26,828.47
18,644.91
14,913.21
Operating Profit (PBDIT) excl Other Income
3706.5
2781.5
2620.1
2501.2
2444
2527.6
2035.3999999999999
Other Income
767.85
4,064.43
793.05
2,556.87
1,070.74
1,236.71
1,128.96
Operating Profit (PBDIT)
7,320.57
9,194.26
5,355.06
6,782.21
5,075.27
4,824.45
4,003.41
Interest
1,120.79
991.33
989.92
1,218.61
1,101.14
665.95
570.39
Exceptional Items
-160.94
-728.23
1,057.41
-330.78
228.46
26.94
10.15
Gross Profit (PBDT)
24,003.78
22,458.37
18,801.73
19,101.79
16,995.21
12,398.75
9,098.73
Depreciation
2,846.27
2,348.29
1,941.90
1,724.10
1,560.56
1,060.12
839.07
Profit Before Tax
3,192.57
5,126.40
3,480.65
3,508.72
2,642.04
3,125.32
2,604.10
Tax
729.03
1,285.24
829.13
886.98
662.95
549.40
409.19
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
4,345.65
5,699.09
4,115.88
3,766.44
3,207.41
3,602.45
3,277.24
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
4,345.65
5,699.09
4,115.88
3,766.44
3,207.41
3,602.45
3,277.24
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
251.95
298.36
311.45
478.40
369.50
531.30
485.48
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
4,597.59
5,997.45
4,427.33
4,244.84
3,576.91
4,133.75
3,762.72
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.12
1.22
1.19
1.12
1.14
1.2
1.12
Reserves
49,997.56
47,876.99
43,795.95
35,606.21
31,839.74
30,335.23
24,692.86
Earnings per share (EPS)
1.63
2.22
1.61
1.3
1.07
1.27
1.2
Diluted Earnings per share
1.63
2.22
1.61
1.3
1.07
1.27
1.2
Operating Profit Margin (Excl OI)
7.28%
5.94%
7.73%
7.77%
8.35%
11.94%
12.01%
Gross Profit Margin
11.85%
15.96%
16.0%
16.26%
14.36%
19.77%
20.32%
PAT Margin
8.53%
12.17%
12.14%
11.7%
10.96%
17.01%
19.34%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2022 is 8.77% vs 38.19% in Dec 2021

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2022 is -23.34% vs 35.47% in Dec 2021

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2022 is 27.74% vs 12.45% in Dec 2021

stock-summary

Interest

YoY Growth in year ended Dec 2022 is 13.06% vs 0.14% in Dec 2021

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2022 has improved from Dec 2021

Compare Annual Results Of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
50,947.30
1,611.64
49,335.66
3,061.21%
Other Operating Income
0.00
0.00
0.00
Total Operating income
50,947.30
1,611.64
49,335.66
3,061.21%
Raw Material Cost
26,943.53
621.44
26,322.09
4,235.66%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
10,884.80
251.44
10,633.36
4,228.99%
Power Cost
0
0
0.00
Manufacturing Expenses
1,120.79
6.48
1,114.31
17,196.14%
Selling and Distribution Expenses
15,294.51
409.63
14,884.88
3,633.74%
Other Expenses
-700.28
-24.88
-675.40
-2,714.63%
Total Expenditure (Excl Depreciation)
47,240.84
1,040.20
46,200.64
4,441.52%
Operating Profit (PBDIT) excl Other Income
3,706.46
571.45
3,135.01
548.61%
Other Income
767.85
62.75
705.10
1,123.67%
Operating Profit (PBDIT)
7,320.57
722.32
6,598.25
913.48%
Interest
1,120.79
6.48
1,114.31
17,196.14%
Exceptional Items
-160.94
0.00
-160.94
Gross Profit (PBDT)
24,003.78
990.21
23,013.57
2,324.11%
Depreciation
2,846.27
88.12
2,758.15
3,129.99%
Profit Before Tax
3,192.57
627.72
2,564.85
408.60%
Tax
729.03
100.61
628.42
624.61%
Provisions and contingencies
0.00
0
0.00
Profit After Tax
4,345.65
500.28
3,845.37
768.64%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
4,345.65
500.28
3,845.37
768.64%
Share in Profit of Associates
0.00
0
0.00
Minority Interest
251.95
28.89
223.06
772.10%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
4,597.59
529.17
4,068.42
768.83%
Equity Capital
0
0
0.00
Face Value
1.12
0.00
0.00
Reserves
49,997.56
4,075.36
45,922.20
1,126.83%
Earnings per share (EPS)
1.63
0.60
1.03
171.67%
Diluted Earnings per share
1.63
0.60
1.03
171.67%
Operating Profit Margin (Excl OI)
7.28%
35.46%
0.00
-28.18%
Gross Profit Margin
11.85%
44.42%
0.00
-32.57%
PAT Margin
8.53%
31.04%
0.00
-22.51%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 5,094.73 Million
in Dec 2022

Figures in Million
stock-summary

YoY Growth in year ended Dec 2022 is 8.77% vs 38.19% in Dec 2021

Annual - Consolidate Net Profit
Consolidate Net Profit 459.76 Million
in Dec 2022

Figures in Million
stock-summary

YoY Growth in year ended Dec 2022 is -23.34% vs 35.47% in Dec 2021

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 655.27 Million
in Dec 2022

Figures in Million
stock-summary

YoY Growth in year ended Dec 2022 is 27.74% vs 12.45% in Dec 2021

Annual - Interest
Interest 112.08 Million
in Dec 2022

Figures in Million
stock-summary

YoY Growth in year ended Dec 2022 is 13.06% vs 0.14% in Dec 2021

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 7.28%
in Dec 2022

Figures in %
stock-summary

YoY Growth in year ended Dec 2022 has improved from Dec 2021